Physician profile
Ronald Pohl
NPI 1700875051
$3,650.62
in general payments reported to CMS, 2019-2025
17 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $104 · 2021: $686 · 2022: $600 · 2023: $69.97 · 2024: $1,312 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $931 · Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $930.58 |
| Food and Beverage | $574.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,131.11 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Edwards Lifesciences Corporation | $748.35 | 2019-2021 | |
| Endologix LLC | $696.16 | 2019-2022 | |
| Atricure, INC. | $571.29 | 2022-2024 | |
| Boston Scientific Corporation | $142.00 | 2019-2025 | Ekosonic, Ranger, General - Thrombectomy |
| Abiomed | $98.56 | 2024-2025 | Impella |
| Terumo Medical Corporation | $47.54 | 2024-2025 | Azur Cx Detachable, Angio-Seal, Glidesheath Slender |
| Janssen Pharmaceuticals, INC | $40.56 | 2019 | |
| Ethicon US, LLC | $35.94 | 2025 | Stratafix, Ethicon |
| Amgen INC. | $28.02 | 2019-2025 | Repatha |
| Amarin Pharma, INC. | $23.96 | 2019 | |
| Solventum Corporation | $20.48 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Chiesi USA, INC. | $16.00 | 2024 | Cleviprex, Kengreal |
| Bard Peripheral Vascular, INC. | $13.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.21 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.81 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Pohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.